TCL Archive Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial July 4, 2014
TCL Archive FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization January 28, 2011
TCL Archive FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one. September 16, 2005
TCL Archive Senate Committee Directs NCI To Conduct Research To Eliminate Barriers To Enrollment On Clinical Trials. July 6, 2007
